Summary & Overview
HCPCS G9786: Pathology Report Not Sent for Cutaneous Skin Cancer within 7 Days
HCPCS Level II code G9786 documents a failure to transmit a pathology report diagnosing cutaneous basal cell carcinoma, squamous cell carcinoma, or melanoma (including in situ) from the pathologist/dermatopathologist to the biopsying clinician within seven days of specimen receipt. Nationally, timely communication of dermatopathology results affects care coordination, follow-up treatment planning, and quality metrics for skin cancer management. This code provides a standardized way to record instances when that communication did not occur in the specified timeframe.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an explanation of the code’s clinical context, typical sites of service, and the service type it represents. The publication outlines benchmarking considerations and payer coverage patterns where available, summarizes policy and claim-processing implications relevant to national payers, and highlights operational points that influence reporting and coding completeness. Data not available in the input is noted where applicable. The content is intended for health policy analysts, coding professionals, and administrative leaders seeking a concise reference on HCPCS Level II code G9786.
Billing Code Overview
HCPCS Level II code G9786 indicates that a pathology report diagnosing cutaneous basal cell carcinoma, squamous cell carcinoma, or melanoma (including in situ disease) was not sent from the pathologist/dermatopathologist to the biopsying clinician for review within 7 days from the time the tissue specimen was received by the pathologist.
-
Service type: Pathology reporting and communication of dermatopathology diagnoses
-
Typical site of service: Dermatology clinics with biopsy services, pathology laboratories, dermatopathology services, and outpatient surgical centers where skin biopsies are performed
Clinical & Coding Specifications
Clinical Context
A 63-year-old male presents to a dermatology clinic with a sun-exposed, irregularly pigmented papule on the nasal ala. The dermatologist performs a punch biopsy and submits the specimen to a dermatopathology laboratory. Within hours the laboratory logs receipt of the specimen and initiates histologic processing. The pathology report identifies invasive basal cell carcinoma. Standard clinical workflow expects the dermatopathologist to finalize and transmit the pathology report to the biopsying clinician (dermatologist or surgeon) so that definitive treatment planning (e.g., Mohs micrographic surgery, surgical excision, or non-surgical therapy) can proceed. The billing code G9786 documents the adverse administrative event in which the pathology report diagnosing cutaneous basal cell carcinoma, squamous cell carcinoma, or melanoma (including in situ disease) was not sent from the pathologist/dermatopathologist to the biopsying clinician for review within 7 days from the time the tissue specimen was received by the pathologist. Typical site of service is an outpatient dermatology clinic or ambulatory surgery center; involved providers include dermatologists, dermatopathologists, and surgical oncologists. Common patient impact is delay in definitive treatment planning and potential need for follow-up communications to locate or retransmit results.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services |